These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2357765

  • 1. Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.
    Parti R, Wolf W.
    Cancer Chemother Pharmacol; 1990; 26(3):188-92. PubMed ID: 2357765
    [Abstract] [Full Text] [Related]

  • 2. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
    Fichtinger-Schepman AM, Vendrik CP, van Dijk-Knijnenburg WC, de Jong WH, van der Minnen AC, Claessen AM, van der Velde-Visser SD, de Groot G, Wubs KL, Steerenberg PA.
    Cancer Res; 1989 Jun 01; 49(11):2862-7. PubMed ID: 2720647
    [Abstract] [Full Text] [Related]

  • 3. cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.
    Reed E, Litterst CL, Thill CC, Yuspa SH, Poirier MC.
    Cancer Res; 1987 Feb 01; 47(3):718-22. PubMed ID: 3802077
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia.
    Vannozzi MO, Ottone M, Mariggiò MA, Cafaggi S, Parodi B, Cilli M, Lindup E, Viale M.
    Anticancer Res; 2003 Feb 01; 23(2B):1509-16. PubMed ID: 12820417
    [Abstract] [Full Text] [Related]

  • 5. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.
    Los G, Mutsaers PH, Lenglet WJ, Baldew GS, McVie JG.
    Cancer Chemother Pharmacol; 1990 Feb 01; 25(6):389-94. PubMed ID: 2311166
    [Abstract] [Full Text] [Related]

  • 6. cis-Platinum: subcellular distribution and binding to cytosolic ligands.
    Sharma RP, Edwards IR.
    Biochem Pharmacol; 1983 Sep 15; 32(18):2665-9. PubMed ID: 6313005
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
    Vadiei K, Siddik ZH, Khokhar AR, al-Baker S, Sampedro F, Perez-Soler R.
    Cancer Chemother Pharmacol; 1992 Sep 15; 30(5):365-9. PubMed ID: 1505075
    [Abstract] [Full Text] [Related]

  • 8. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
    Tokunaga Y, Nakashima M, Sasaki H, Tomiyama N, Nakashima MN, Ichikawa M, Kaminogo M, Shibata S.
    Biol Pharm Bull; 2000 Dec 15; 23(12):1491-6. PubMed ID: 11145184
    [Abstract] [Full Text] [Related]

  • 9. Intracellular metabolites of cisplatin in the rat kidney.
    Mistry P, Lee C, McBrien DC.
    Cancer Chemother Pharmacol; 1989 Dec 15; 24(2):73-9. PubMed ID: 2731314
    [Abstract] [Full Text] [Related]

  • 10. [Basic studies on optimal intra-arterial infusion rate of cisplatin].
    Kishimoto S, Fukushima S, Hayashi Y, Nakano M, Miyazaki K, Okamura H.
    Gan To Kagaku Ryoho; 1989 Aug 15; 16(8 Pt 2):2788-91. PubMed ID: 2782889
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Zuhowski EG, Pluim D, Joseph E, Hamburger DR, Working PK, Colbern G, Tonda ME, Potter DM, Eiseman JL.
    Cancer Chemother Pharmacol; 2004 Apr 15; 53(4):329-36. PubMed ID: 14673619
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
    Newman MS, Colbern GT, Working PK, Engbers C, Amantea MA.
    Cancer Chemother Pharmacol; 1999 Apr 15; 43(1):1-7. PubMed ID: 9923534
    [Abstract] [Full Text] [Related]

  • 19. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Hamburger DR, Delauter BJ, Grim A, Zuhowski EG, Joseph E, Pluim D, Potter DM, Eiseman JL.
    Clin Cancer Res; 2002 Sep 15; 8(9):2992-9. PubMed ID: 12231546
    [Abstract] [Full Text] [Related]

  • 20. [Studies on pharmacokinetics of platinum after internal iliac artery infusion of cisplatin in rabbits].
    Kanamori Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jan 15; 45(1):31-7. PubMed ID: 8436840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.